TORONTO, ONTARIO / ACCESSWIRE / April 30, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it is relying on the coordinated relief provided by securities regulators, which consists of a 45-day extension for certain periodic filings required on or before June 1, 2020, pursuant to Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements and similar exemptions in other provinces (collectively, the "Blanket Relief"). CardioComm is relying on the Blanket Relief with respect to the requirement to file:

within 120 days of the Company's financial year end, audited financial statements, management's discussion and analysis, and certifications for the year ended December 31, 2019; and
within 60 days of the Company's financial quarter, interim financial statements, management's discussion and analysis, and certifications for the quarter ended March 31, 2020.

CardioComm is continuing to work diligently and expeditiously to file its annual documents for the year ended December 31, 2019, and the quarterly documents for the quarter ended March 31, 2020. CardioComm currently expects such documents to be filed on or about May 29, 2020, and June 19, 2020, respectively.

CardioComm confirms that there have been no material developments, other than those disclosed through news releases, since the filing of its interim consolidated financial statements for the period ended September 30, 2019.

CardioComm advises that, in accordance with the requirements of the Blanket Relief, management and other insiders of CardioComm are subject to a trading blackout that reflects the principles in Section 9 of National Policy 11-207 Failure to-File Cease Trade Orders and Revocations in Multiple Jurisdictions until its filings are up to date.

To learn more about CardioComm's products and for further updates regarding HeartCheck™ ECG device integrations please visit the Company's websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
egrima@cardiocommsolutions.com
investor.relations@cardiocommsolutions.com

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management's current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc

ReleaseID: 587883

LOS ANGELES, CA / ACCESSWIRE / April 30, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against NMC Health Plc ("NMC Health" or "the Company") (OTC PINK:NMHLY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between March 13, 2016 and March 10, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. NMC Health failed to maintain effective internal controls. The Company engaged in numerous related-party transactions. The Company understated its debts while simultaneously overstating its cash-on-hand. NMC Health's principal shareholders did not accurately report their interest in the Company, which did not review the ownership stakes of these principal shareholders, and therefore could not enforce its Relationship Agreement with them. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about NMC Health, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 587894

LOS ANGELES, CA / ACCESSWIRE / April 30, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against World Wrestling Entertainment, Inc. ("WWE" or "the Company") (NYSE:WWE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 7, 2019 and February 5, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before May 5, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. WWE suffered from increasing tensions with the government of Saudi Arabia, including a breakdown of negotiations over the renewal of its broadcasting distribution deal. The Saudi government failed to make payments to the Company number in the millions of dollars. One such payment for a June 2019 event amounted to $60 million. Orbit Showcase Network ("OSN") terminated WWE broadcasts in the first quarter of 2019, despite its contractual obligations to continue. OSN's actions, along with rebuffing renewal efforts, made the likelihood of a renewal in 2019 or the future very small. WWE lacked the capacity to expand its operations in the Middle East or within Saudi Arabia, despite what it had promised investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about WWE, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 587889

SAN FRANCISCO, CA / ACCESSWIRE / April 30, 2020 / Hagens Berman urges investors in ServiceMaster Global Holdings, Inc. (NYSE:SERV) who have suffered significant losses to submit their losses now. A securities fraud class action is pending and certain investors may have valuable claims.

Class Period: Feb. 26, 2019 – Nov. 4, 2019

Lead Plaintiff Deadline: June 9, 2020

Sign Up: www.hbsslaw.com/investor-fraud/SERV

Contact An Attorney Now: SERV@hbsslaw.com

844-916-0895

ServiceMaster (SERV) Securities Class Action:

The complaint concerns Defendants' concealment of the financial risks presented to ServiceMaster's Terminix business arising from Formosan: an invasive termite impacting the Gulf Coast region, particularly Mobile, Alabama.

The complaint alleges that throughout the Class Period, Defendants represented that ServiceMaster was successfully executing upon initiatives to improve the performance in the Terminix segment. In addition, Defendants stated that Terminix would reach a positive "inflection point" and was "definitely the driver" for positive trends in the second half of 2019. Unbeknownst to investors, however, in the past several years the Terminix segment had experienced an adverse trend of costly termite litigation, primarily related to Formosan activity.

Investors began to learn the truth, according to the complaint, when the company announced disappointing preliminary Q3 2019 financial results on Oct. 22, 2019. Defendants blamed the poor performance on "termite damage claims arising primarily from Formosan termite activity" primarily in Mobile, Alabama. Defendants also announced (1) this was a known issue and the company commenced mitigation efforts "starting in 2018," and (2) the President of Terminix Residential suddenly departed.

Then, on Nov. 5, 2019, ServiceMaster released its final Q3 2019 financial results, informing investors that (1) the increase in termite claims litigation that occurred "[i]n the past few years" impacted termite revenue by 7-8%, (2) these issues would continue throughout 2020, and (3) price increases in Mobile were part of an effort to "mitigate" termite damage claims.

These disclosures have driven the price of ServiceMaster shares sharply lower.

"We're focused on investors' losses and proving Defendants intentionally misled ServiceMaster investors about the financial health of its core Terminix business," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding ServiceMaster should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SERV@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:
Reed Kathrein
844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 587882

NEW YORK, NY / ACCESSWIRE / April 30, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

VMware, Inc. (NYSE:VMW)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/vmware-inc-loss-submission-form?prid=6279&wire=1
Lead Plaintiff Deadline: June 1, 2020
Class Period: March 30, 2019 to February 27, 2020

Allegations against VMW include that: (i) VMware's reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (ii) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Mesa Air Group Incorporated (NASDAQ:MESA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/mesa-air-group-incorporated-loss-submission-form?prid=6279&wire=1
Lead Plaintiff Deadline: June 1, 2020
Class Period: shares pursuant and/or traceable to the documents issued in connection with Mesa Air Group's August 2018 initial public offering.

Allegations against MESA include that: (1) Mesa Air Group's operational performance was poor and below industry standards; (2) Mesa Air Group had a shortage of qualified mechanics and maintenance personnel; (3) Mesa Air Group had an inadequate number of spare aircraft and parts; (4) Mesa Air Group did not have a strong track record of reliable performance; (5) then-existing "risks" had already materialized; (6) Mesa Air Group knew of undisclosed adverse trends and uncertainties at the time of the initial public offering; and (7) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Liberty Oilfield Services, Inc. (NYSE:LBRT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/liberty-oilfield-services-inc-loss-submission-form?prid=6279&wire=1
Lead Plaintiff Deadline: June 2, 2020
Class Period: securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.

Allegations against LBRT include that: (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing, and its competition was not decreasing; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more, contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 587881

SAN FRANCISCO, CA / ACCESSWIRE / April 30, 2020 / Hagens Berman urges RTI Surgical Holdings (NASDAQ:RTIX) investors who have suffered significant losses to submit their loss now. A securities fraud class action has been filed and important investor deadlines are fast approaching.

Class Period: Mar. 7, 2016 – Mar. 16, 2020
Lead Plaintiff Deadline: May 22, 2020
Sign Up: www.hbsslaw.com/investor-fraud/RTIX
Contact an Attorney Now: RTIX@hbsslaw.com
844-916-0895

RTI Surgical Holdings, Inc. (RTIX) Securities Class Action:

The Complaint alleges that Defendants misrepresented and concealed that the Company inappropriately recognized revenues, including with its other equipment manufacturer (OEM) customers.

The truth emerged, according to the Complaint, on Mar. 17, 2020 when the Company announced it would not timely file its 2019 annual report. Defendants blamed the delay on an ongoing investigation into "the Company's revenue recognition practices involving the timing of revenue recognition with respect to certain contractual arrangements, primarily with OEM customers." This news drove the price of RTI Surgical shares sharply lower on Mar. 17, 2020.

Recent developments have strengthened investors' securities fraud claims. On Mar. 20, 2020, the Company announced the termination of Johannes W. Louw, RTI Surgical's former interim CFO, who headed the Company's financial planning and analysis.

Most recently, on Apr. 9, 2020, the company announced it will restate all previously audited financial statements for 2014 – 2018, and its unaudited financial statements for the quarterly periods for 2016 – 2018 and the nine months ended Sept. 30, 2019. The Company explained, in effect, it recognized revenue prematurely by shipping products to customers earlier than agreed upon. The Company further noted that on some "occasions the goods were delivered early without obtaining the customers' affirmative approval." Additionally, the Company divulged that in July 2017, an adjustment was improperly made to a product return provision in the Direct Division.

"We're focused on recovering investors' losses and proving that RTI Surgical engaged in improper revenue recognition practices to deceive investors into believing it was more profitable," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding RTI Surgical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email RTIX@hbsslaw.com.

# # #

About Hagens Berman

Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:

Reed Kathrein
844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 587880

SAN FRANCISCO, CA / ACCESSWIRE / April 30, 2020 / Hagens Berman urges investors in Paysign, Inc. (NASDAQ:PAYS) who have suffered significant losses to submit their losses now. A securities class action is pending, and certain investors may have valuable claims.

Class Period: Mar. 12, 2019 – Mar. 15, 2020

Lead Plaintiff Deadline: May 18, 2020

Sign Up: www.hbsslaw.com/investor-fraud/PAYS

Contact An Attorney Now: PAYS@hbsslaw.com

844-916-0895

Paysign, Inc. (PAYS) Securities Class Action:

The complaint alleges that Defendants made materially false and misleading statements concerning Paysign's operations, financial performance, and business prospects. According to the complaint, throughout the Class Period, Defendants misrepresented and concealed that: (1) Paysign's internal control over financial reporting was not effective; and (2) Paysign's information technology general controls were not effective.

The truth emerged on Mar. 16, 2020, when Paysign announced it would not timely file its 2019 annual report with the SEC. Paysign explained that its "management identified material weaknesses related to (i) assessment of internal controls over financial reporting and (ii) [IT] general controls." This news drove the price of Paysign shares sharply lower.

Recently, on Mar. 31, 2020, Paysign announced a second delay in the release of its 2019 annual financial results, again due to material weaknesses in its controls. This additional delay caused the price of Paysign shares to decline again.

"We're focused on investors' losses and proving Paysign falsely affirmed the effectiveness of its internal controls," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding Paysign should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email PAYS@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers, and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news, visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:
Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 587879

SAN FRANCISCO, CA / ACCESSWIRE / April 30, 2020 / Hagens Berman urges investors in GSX Techedu Inc. (NYSE: GSX) who have suffered significant losses to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

Class Period: June 6, 2019 – Apr. 13, 2020

Lead Plaintiff Deadline: June 16, 2020

Sign Up: www.hbsslaw.com/investor-fraud/GSX

Contact An Attorney Now: GSX@hbsslaw.com

844-916-0895

GSX Techedu (GSX) Securities Class Action:

The Complaint alleges that throughout the Class Period, Defendants overstated GSX's profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process.

Investors began to learn the truth, according to the Complaint, beginning on Feb. 25, 2020 when Grizzly Research published a scathing report, "Brushed Student Counts and Cooked Books: Why We Believe GSX Techedu is the Worst Publicly Traded Education Company." According to the report: (1) the company "has been drastically overstating its profitability in its US public filings, especially for 2018;" (2) Grizzly "found multiple strong indications of past and current order ‘brushing'" which are "fake student enrollments to boost student count;" (3) "many of GSX's reported students do not actually exist;" and, (4) "[w]hile [GSX] touts its high-quality teacher recruitment mechanism, [Grizzly] found a website that was not functional, multiple allegations of GSX hiring teachers right out of college, with no prior experience, and fabricated teachers profiles."

Then, on Apr. 14, 2020, Citron Research published its own cutting report, "GSX Techedu Inc. – The Most Blatant Chinese Stock Fraud Since 2011," accusing GSX of fabricating up to 70% of its revenues. According to the report, GSX's Chinese official government financials and SEC financials are irreconcilable and show a 75% overstatement of net profits for FY 2017 – 2018 alone.

These revelations have driven the price of GSX ADSs sharply lower.

"We're focused on investors' losses and proving GSX and its senior management intentionally mislead investors," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding GSX should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email GSX@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers, and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news, visit our newsroom or follow us on Twitter at @classactionlaw.

CONTACT:
Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 587878

NEW YORK, NY / ACCESSWIRE / April 30, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Provident Financial Services, Inc. ("Provident" or "the Company") (NYSE:PFS). Investors who purchased Provident securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/pfs.

The investigation concerns whether Provident and certain of its officers and/or directors have violated federal securities laws.

On April 30, 2020, Provident announced its financial and operating results for the first quarter of 2020. The Company "reported net income of $14.9 million, or $0.23 per basic and diluted share, for the three months ended March 31, 2020, compared to net income of $30.9 million, or $0.48 per basic and diluted share, for the three months ended March 31, 2019." Provident Financial services advised investors that its earnings were "adversely impacted by elevated provisions for credit losses primarily due to the adoption of a new accounting standard that requires the current recognition of allowances for losses expected to be incurred over the life of covered assets," which provisions "were exacerbated by the current weak economic forecast attributable to the COVID-19 pandemic." On this news, Provident's stock price fell sharply during intraday trading on April 30, 2020.

If you are aware of any facts relating to this investigation, or purchased Provident shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/pfs. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 587874

NEW YORK, NY / ACCESSWIRE / April 30, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walmart, Inc. ("Walmart" or "the Company") (NYSE:WMT). Investors who purchased Walmart securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/wmt.

The investigation concerns whether Walmart and certain of its officers and/or directors have violated federal securities laws.

On April 29, 2020, multiple media outlets reported on the filing of a class action lawsuit against Walmart, along with other food retailers, accusing them of illegally inflating the price of eggs sold in California amid skyrocketing demand due to the COVID-19 pandemic. Following reports of the lawsuit, Walmart's stock price fell $4.40 per share, or 3.44%, to close at $123.60 per share on April 29, 2020.

If you are aware of any facts relating to this investigation, or purchased Walmart shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/wmt. You can also contact Peretz Bronstein of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 587871